The Department of Health Services (DoHS) in Nepal has initiated the procurement process for F-75 and F-100 therapeutic milks, according to a recent public notice. While the announcement itself is brief, its implications for public health, particularly for the most vulnerable children, are profound. This step ensures a steady supply of these critical nutritional formulas, which are indispensable in the fight against severe acute malnutrition (SAM) within the country. ## Understanding Severe Acute Malnutrition (SAM) Severe acute malnutrition is a grave and life-threatening condition, predominantly affecting young children. It is characterized by extremely low weight-for-height (wasting), visible severe wasting, or the presence of nutritional edema (swelling, usually in the feet). Children suffering from SAM have significantly weakened immune systems, making them highly susceptible to common childhood illnesses like pneumonia, diarrhea, and measles. Without timely and appropriate intervention, SAM can lead to permanent developmental delays, cognitive impairment, and tragically, death. The causes of SAM are complex and multifaceted, often intertwined with poverty, food insecurity, poor sanitation, inadequate access to healthcare, and recurrent infections. In regions like Nepal, factors such as challenging geography, natural disasters, and limited access to nutritious food sources can exacerbate the problem. Ensuring that children receive proper nutrition, especially during their crucial early developmental years, is foundational for their future health and the nation's progress. ## The Role of F-75 and F-100 Therapeutic Milks F-75 and F-100 are specialized therapeutic milk formulas developed by the World Health Organization (WHO) specifically for the hospital-based treatment of severe acute malnutrition. They are not ordinary infant formulas but meticulously designed medical foods tailored to meet the unique physiological needs of severely malnourished children during different stages of their recovery. These formulas are integral to the two-phase approach to managing SAM in inpatient settings, typically in nutrition rehabilitation centers or hospitals. This structured treatment protocol is crucial because severely malnourished children cannot be treated with standard foods or rapid refeeding, which can overwhelm their fragile systems and lead to fatal complications. ## Phase 1: Stabilization with F-75 The initial phase of treatment focuses on stabilizing the child’s condition. During this critical period, children with SAM often present with complications such as dehydration, electrolyte imbalances, hypoglycemia (low blood sugar), hypothermia (low body temperature), and severe infections. Their digestive systems are also severely compromised. F-75 therapeutic milk is specifically formulated for this stabilization phase. It is characterized by its lower protein, lower fat, and higher carbohydrate content compared to standard milk. It also contains precise amounts of vitamins and minerals, with particular emphasis on potassium and magnesium, and reduced sodium, to correct the severe electrolyte disturbances common in SAM. The low osmolarity and lactose content make it gentle on a compromised gut. The primary goals of using F-75 are to slowly rehydrate the child, gradually restore metabolic function, correct electrolyte imbalances, and prevent refeeding syndrome – a dangerous shift in fluids and electrolytes that can occur with too-rapid nutrient intake. This careful, gradual approach allows the child's body to prepare for the more intensive nutritional rehabilitation that follows, without causing further stress or complications. ## Phase 2: Rehabilitation with F-100 Once the child is stabilized, typically after a few days and when complications have resolved, they transition to the rehabilitation phase. This is where F-100 therapeutic milk becomes vital. F-100 is a high-energy, high-protein, and high-fat formula designed to promote rapid weight gain and catch-up growth. With higher caloric and nutrient density than F-75, F-100 supports the rapid tissue repair and growth necessary for a child to recover from the devastating effects of malnutrition. It helps replenish nutrient stores, rebuild muscle mass, and strengthen the immune system. During this phase, children typically show a marked increase in appetite and begin to gain weight steadily. The transition from F-75 to F-100 is a sign of progress, indicating the child is strong enough to handle more intensive nutrition. Following successful inpatient rehabilitation with F-75 and F-100, children are often discharged to continue their recovery at home using Ready-to-Use Therapeutic Food (RUTF), like Plumpy'Nut, which allows for continued nutritional support in an outpatient setting, reducing the burden on healthcare facilities and improving adherence to treatment. ## Nepal’s Commitment to Child Health and Nutrition The procurement notice by the DoHS for F-75 and F-100 underscores the government’s unwavering commitment to addressing malnutrition, a critical public health challenge in Nepal. By ensuring a consistent supply of these life-saving products, the authorities are equipping health facilities across the country with the necessary tools to effectively manage and treat severe acute malnutrition. This initiative is a testament to the ongoing efforts to safeguard the health and well-being of Nepalese children, providing them with a chance at a healthier future. Such procurements are not isolated actions but part of broader national health strategies. Nepal has made significant strides in improving child health indicators over the years, thanks to concerted efforts in immunization, sanitation, and nutrition programs. The continued investment in essential medical supplies, like therapeutic milks, is a crucial component of these efforts, reinforcing the healthcare system's capacity to respond to the most pressing health needs. ## Beyond Therapeutic Milks: Other Vital Procurements The same DoHS notice also briefly mentions other critical procurement initiatives, including Equine Anti-Rabies Immunoglobulin, Anti-snake Venom Serum (ASVS), and Vitamin A capsules. These also highlight the comprehensive nature of public health supply chain management in Nepal. Equine Anti-Rabies Immunoglobulin is a vital post-exposure prophylaxis for individuals bitten by rabid animals, offering immediate protection before the rabies vaccine can take full effect. Given the prevalence of rabies in some parts of Nepal, securing this supply is crucial for preventing a deadly disease. Anti-snake Venom Serum (ASVS) is the only effective treatment for snakebite envenoming, a significant public health issue, particularly in the agricultural plains of Nepal. Timely access to ASVS can mean the difference between life and death for snakebite victims. Finally, Vitamin A capsules are a cornerstone of child survival programs globally. Vitamin A deficiency weakens the immune system, increases susceptibility to infections, and can lead to blindness. Regular supplementation is a highly cost-effective intervention that significantly reduces child mortality and improves overall health. These procurements collectively demonstrate a strategic approach to ensuring the availability of essential medicines and nutritional supplements across various public health priorities. ## A Future of Better Health By actively procuring F-75, F-100, and other vital medical supplies, the Department of Health Services is taking concrete steps to strengthen Nepal's healthcare infrastructure and improve health outcomes for its population. These efforts are fundamental in building a resilient health system capable of protecting its citizens from preventable diseases and ensuring every child has the opportunity to grow, thrive, and reach their full potential. It's a clear signal of the nation's dedication to securing a healthier tomorrow.